ARTL (Artelo Biosciences) Shiller PE Ratio: (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ARTL Artelo Biosciences Inc ARTL
32 GF Score
Price $5.92
! 2 Warning Signs
View Full Analysis

What is Artelo Biosciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Artelo Biosciences  (NAS:ARTL) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Artelo Biosciences Shiller PE Ratio Related Terms


Artelo Biosciences Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Artelo Biosciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artelo Biosciences Shiller PE Ratio Chart

Artelo Biosciences Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Artelo Biosciences Quarterly Data
Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ARTL vs PPCB, CLDI, GNPX: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Artelo Biosciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artelo Biosciences Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artelo Biosciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Artelo Biosciences's Shiller PE Ratio falls into.


ARTL
32GF Score
Artelo Biosciences Inc ARTL
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artelo Biosciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Artelo Biosciences's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Artelo Biosciences's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-8.01/333.9520*333.9520
=-8.010

Current CPI (Jun. 2026) = 333.9520.

Artelo Biosciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201608 -11.020 240.849 -15.280
201611 -24.216 241.353 -33.507
201702 -33.107 243.603 -45.386
201705 -191.730 244.733 -261.626
201708 -198.847 245.519 -270.469
201711 -475.226 246.669 -643.383
201802 -1,255.447 248.991 -1,683.832
201805 -879.539 251.588 -1,167.479
201808 -958.490 252.146 -1,269.462
201811 -760.796 252.038 -1,008.060
201902 -527.033 252.776 -696.283
201905 -399.170 256.092 -520.530
201908 -612.754 256.558 -797.599
201911 -947.700 257.208 -1,230.468
202002 -972.000 258.678 -1,254.847
202005 -656.100 256.394 -854.567
202008 -486.000 259.918 -624.430
202011 -340.200 260.229 -436.579
202102 -267.300 263.014 -339.394
202105 -243.000 269.195 -301.456
202108 -165.240 273.567 -201.714
202111 -194.400 277.948 -233.570
202203 -113.400 287.504 -131.720
202206 -140.940 296.311 -158.844
202209 -132.840 296.808 -149.464
202212 -191.160 296.797 -215.091
202303 -123.120 301.836 -136.220
202306 -90.720 305.109 -99.296
202309 -134.460 307.789 -145.890
202312 -160.380 306.746 -174.604
202403 -126.360 312.332 -135.107
202406 -122.040 314.175 -129.722
202409 -56.700 315.301 -60.054
202412 -189.540 315.605 -200.558
202503 -112.950 319.799 -117.949
202506 -151.740 322.561 -157.099
202509 -107.190 324.800 -110.210
202512 -55.712 324.054 -57.414
202603 -36.000 330.213 -36.408
202606 -8.010 333.952 -8.010

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Artelo Biosciences Business Description

Address 505 Lomas Santa Fe, Suite 160, Solana Beach, CA, USA, 92075
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
32GF Score

Get the complete analysis for ARTL

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.92
Price